• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns

Press release

September 18, 2010 By Jonathan Leave a Comment

NO CANCER FOUNDATION
September 17th, 2010

The fate of all girls from 12 to 18 years in the European Union, to be injected with the Gardasil vaccine against cervical cancer, is held by a number of 27 government officials, one per country.

The European Union has 27 Member States. Every Member State has one representative in ‘The Committee for Medicinal Products for Human Use (CHMP)’.

The representatives per country are:

Belgium: Pieter Neels; The Netherlands: Barbara van Zwieten-Boot; Luxembourg: Jacqueline Genoux-Hames; France: Pierre Demolis; Germany: Harald Enzmann; Italy: Daniela Melchiorri; Spain: Gonzalo Calvo Rojas; Austria: Laslop; Bulgaria: Mila Vlaskovska; Cyprus: Arthur Isseyegh; Czech Republic: Ondřej Slanař; Denmark: Jens Ersbøll; Finland: Jaana Kallio; Greece: George Aislaitner; Hungary: Agnes Gyurasics; Estonia: Alar Irs; Iceland: Sif Ormarsdóttir; Ireland: David Lyons; Latvia: Juris Pokrotnieks; Lithuania: Romaldas Mačiulaitis; Malta: John Joseph Borg; Norway: Eva Skovlund; Poland: Piotr Fiedor; Portugal: Beatriz Silva Lima; Romania: Robert Ancuceanu; Slovakia: Jan Mazag; Slovenia: Metoda Lipnik-Stangelj; Sweden: Tomas Salmonson; Great Britain: Ian Hudson.

For details on telephone numbers and addresses, read here.

After evaluation by the CHMP, Sanofi Pasteur MSD, was licensed by the European Commission in 2006, the marketing of the Gardasil vaccine for the U.S. based company MERCK & CO, Inc., so to inject all girls in the age of 12 – 18 years old with it, within the 27 countries of the European Union.

With the consent of abovementioned officials (one per country) and without prior decision of the responsible ministers of the 27 Member States, Gardasil vaccines, produced by the American company MERCK & CO, Inc., may be injected in all European girls from 12 – 18 years old in the 27 countries of the European Union. This means that in today’s Europe, with open borders, in 27 countries the fate of all girls in the age between 12 and 18 years is in the hands of 27 officials. For Belgium, this official is Mr. Pieter Neels. Mr. Neels does not know the chemical composition of Gardasil, which has been and will be injected three times in every girl, aged 12 – 18.

As factual proof, please read the attached e-mail, dated September 17, 2010 written by Mr. A.M.L. van Rooij, Recognized Safety Manager by the European Union, on behalf of the No Cancer Foundation (read here). If Mr. Neels doesn’t know the chemical composition, the other 26 members, representing the member states, don’t know the composition either. Herewith it has actually been established that not only Mr. Neels, but also the officials, representing the other 26 member states, have violated very seriously Rule 168 (Title XIV, Public Health), Article 169 (TITLE XIV, consumer protection) and Article 191 (TITLE XX Environment) of the Lisbon Treaty, dated December 1st, 2009.

In case Mr. Pieter Neels has not produced the chemical composition, as requested by Safety Manager Mr. A.M.L. van Rooij in his e-mail dated September 17, 2010 (read here) within 48 hours of today, No Cancer Foundation will file a complaint with the European Commission against the above mentioned officials in all Member States, because of a very serious violation of the above mentioned articles of the Treaty of Lisbon, which came into force December 1st, 2009. This press release will be part of that complaint.

More

Filed Under: Cervarix, Gardasil / Silgard

More pushing (and more victims) of the vaccine against human papillomavirus

September 16, 2010 By Jonathan Leave a Comment

Pravda Ru
Miguel Jara
Rebellion

September 16, 2010

There is an ongoing campaign to expand the controversial human papillomavirus vaccination, PTO. So far, one would only vaccinate young girls, but the European Commission has extended its administration to women up to 45 years. There are some things worth noting. The first is that they used this vaccine and it was recommended for girls who had not initiated sexual intercourse. According to a study of the criteria for preparation, Gardasil, from Merck, if the female was infected there was a 44.6% chance of uterine cancer. Now it seems that they are ignoring this study.

Filed Under: Cervarix, Cervical Cancer HPV, Endocrine System, Gardasil / Silgard, Nervous System Tagged With: cervarix, Cervical Cancer HPV, Gardasil/Silgard, HPV, HPV VACCINES, immunizations, vaccinations, Vaccine Adverse Reactions

Procedural, ethical lapses found in HPV vaccine trials in AP, Gujarat

September 15, 2010 By Jonathan Leave a Comment

Pharmabiz

Wednesday, September 15, 2010 08:00 IST
Joseph Alexander, New Delhi

The three-member inquiry committee set up by the Health Ministry to investigate the deaths of six children in Andhra Pradesh and Gujarat who were administered the controversial Human Papilloma Virus (HPV) vaccine is yet to submit its report even after four months against the mandated one month.

Filed Under: Cervarix, Cervical Cancer HPV, Endocrine System, Gardasil / Silgard, Nervous System Tagged With: cervarix, Cervical Cancer HPV, Gardasil/Silgard, HPV, HPV VACCINES, Merck, vaccinations, Vaccine Adverse Reactions

Etiology and Risk Factors for Developing Orthostatic Hypotension

September 15, 2010 By Jonathan 1 Comment

Skip Navigation Links
American Journal of Therapeutics:

January/February 2010 – Volume 17 – Issue 1 – pp 86-91
doi: 10.1097/MJT.0b013e3181a2b1bb
Therapeutic Review

Mosnaim, Aron D PharmD, PhD; Abiola, Rasheed BS; Wolf, Marion E MD; Perlmuter, Lawrence C PhD

Orthostatic hypotension (OH) is regarded as a decrease primarily in systolic blood pressure on changing position from supine to erect. Based on clinical criteria, it is characterized by a decrease in systolic pressure of 20 mmHg and diastolic pressure of 10 mmHg within 1 to 3 minutes of standing after being supine. It is most prevalent in, although not limited to, the elderly population and is characterized by a variety of problems, including diminished cognition and disturbed emotion along with gate problems, falls, and brain and cardiovascular difficulties.

Filed Under: Cervarix, Gardasil / Silgard, Nervous System Tagged With: cervarix, Cervical Cancer HPV, Gardasil/Silgard, HPV, HPV VACCINES, Vaccine Adverse Reactions

Ampiginous choroiditis following quadrivalent human papilloma virus vaccine

September 15, 2010 By Jonathan Leave a Comment

Case report

A 17-year-old female was referred for new-onset vision loss in both eyes 3 weeks after being vaccinated with the quadrivalent HPV vaccine. A standard dose of 0.5 ml was injected intramuscularly into the left deltoid without any resulting skin reaction. Her medical history was significant for depression treated with quetiapine. Three weeks following vaccination, she developed painless vision loss in the left eye …

Filed Under: Cervarix, Cervical Cancer HPV, Endocrine System, Gardasil / Silgard, Nervous System Tagged With: cervarix, Cervical Cancer HPV, Gardasil/Silgard, GlaxoSmithKline, HPV, HPV VACCINES, Merck, vaccinations, Vaccine Adverse Reactions

  • « Previous Page
  • 1
  • …
  • 375
  • 376
  • 377
  • 378
  • 379
  • …
  • 393
  • Next Page »

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

HPV Vaccines: My Journey Through Gardasil Injuries

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Subscribe2


 

Log In

Featured Video

HPV Vaccine Safety Efficacy Issues: Dr. Tomljenovic

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in